ADAMTS-13 activity in von Willebrand disease

Thrombosis Research

Volumn 117, Issue 6, 2006, Pages 685-688

  Perutelli, Paolo ^a   Amato, Stefano ^a   Molinari, Angelo C ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

ADAMTS 13; von Willebrand disease; von Willebrand factor

Indexed keywords

VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; VON WILLEBRAND DISEASE;

ADAM PROTEINS; ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; VARIATION (GENETICS); VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 33646017091     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.05.018     Document Type: Article

References (17)

1. Tsai H.-M. Shear stress and von Willebrand factor in health and disease. Semin Thromb Hemost 29 (2003) 479-488
2. Dong J.-F., Moake J.L., Nolasco L., Bernardo A., Arceneaux W., Shrimpton C.N., et al. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 100 (2002) 4033-4039
3. Kokame K., Matsumoto M., Fujimura Y., and Miyata T. VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13. Blood 103 (2004) 607-612
4. Arya M., Anvari B., Romo G.M., Cruz M.A., Dong J.-F., McIntire L.V., et al. Ultralarge multimers of von Willebrand factor forms spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers. Blood 99 (2002) 3971-3977
5. Furlan M. Proteolytic cleavage of von Willebrand factor by ADAMTS-13 prevents uninvited clumping of blood platelets. J Thromb Haemost 2 (2004) 1505-1509
6. Peyvandi F., Ferrari S., Lavoretano S., Canciani M.T., and Mannucci P.M. von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura. Br J Haematol 127 (2004) 433-439
7. Moake J.L. Defective processing of unusually large von Willebrand factor multimers and thrombotic thrombocytopenic purpura. J Thromb Haemost 2 (2004) 1515-1521
8. Mannucci P.M., Canciani M.T., Forza I., Lussana F., Lattuada A., and Rossi E. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood 98 (2001) 2730-2735
9. Mannucci P.M., Capoferri C., and Canciani M.T. Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease. Br J Haematol 126 (2004) 213-218
10. Bowen D.J., Collins P.W., Lester W., Cumming A.M., Keeney S., Grundy P., et al. The prevalence of the cysteine 1584 variant von Willebrand factor is increased in type 1 von Willebrand disease: co-segregation with increased susceptibility to ADAMTS-13 proteolysis but not clinical phenotype. Br J Haematol 128 (2005) 830-836
11. Federici A.B., Castaman G., and Mannucci P.M. Guidelines for the diagnosis and management of von Willebrand disease in Italy. Haemophilia 8 (2002) 607-621
12. Gerritsen H., Turecek P., Schwarz H.P., Lämmle B., and Furlan M. Assay of von Willebrand factor (VWF)-cleaving protease based on decreased collagen binding affinity of degraded VWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Thromb Haemost 82 (1999) 1386-1389
13. Nishino M., Girma J.-P., Rothschild C., Fressinaud E., and Meyer D. New variant of von Willebrand disease with defective binding to factor VIII. Blood 74 (1989) 1591-1599
14. Sadler J.E. A revised classification of von Willebrand disease. Thromb Haemost 71 (1994) 520-525
15. Tsai H.-M., Sussman I.I., Ginsburg D., Lankhof H., Sixma J.J., and Nagel R.L. Proteolytic cleavage of recombinant von Willebrand factor mutants R834W and R834Q: inhibition by doxycycline and by monoclonal antibody VP-1. Blood 89 (1997) 1954-1962
16. O'Brien L.A., Sutherland J.J., Hegadorn C., Benford K., Racz H., Rapson D., et al. A novel type 2A (group II) von Willebrand disease mutation (L1503Q) associated with loss of the highest molecular weight von Willebrand factor multimers. J Thromb Haemost 2 (2004) 1135-1142
17. Ruggeri Z.M. Type IIB von Willebrand disease: a paradox explains how von Willebrand factor works. J Thromb Haemost 2 (2004) 2-6